Home >> Marketplace Directory >> Transgenomic, Horizon OEM agreement, 8/15

Transgenomic, Horizon OEM agreement, 8/15

image_pdfCreate PDF

Horizon Discovery Group and Transgenomic announced a new original equipment manufacturer agreement to incorporate Horizon’s human genomic reference standards, produced by Horizon’s diagnostics division, into Transgenomic’s Multiplexed ICE COLD-PCR (MX-ICP) kits for use in research and clinical applications. Further details of the agreement were not disclosed.

This agreement follows a collaborative project initiated in 2014 between Horizon Diagnostics and Transgenomic, which explored the utility of Horizon’s advanced reference standards in Transgenomic’s in vitro DNA mutation enrichment kits. The standards are being used in both quality control and mutation concentration assays.

Transgenomic’s MX-ICP technology delivers a sensitivity improvement of at least 100-fold in comparison to standard methodologies and enriches both known and previously unknown genetic alterations using a single multiplexed assay. The ultra-high sensitivity of MX-ICP makes it feasible to conduct comprehensive genomic analyses using either tissue biopsies or liquid samples such as blood or urine.

Horizon Discovery Group, +44 (0)1223 655 580

Transgenomic, 402-452-5400

CAP TODAY
X